QLENX
Price
$15.57
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
SRUAX
Price
$14.65
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

QLENX vs SRUAX

Header iconQLENX vs SRUAX Comparison
Open Charts QLENX vs SRUAXBanner chart's image
AQR Long-Short Equity N
Price$15.57
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Meeder Spectrum Adviser
Price$14.65
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
QLENX vs SRUAX Comparison Chart
Loading...
VS
QLENX vs. SRUAX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QLENX is a Hold and SRUAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 1.93B vs. SRUAX (220M). QLENX pays higher dividends than SRUAX: QLENX (18.52) vs SRUAX (1.46). QLENX was incepted earlier than SRUAX: QLENX (11 years) vs SRUAX (8 years). SRUAX is a more actively managed with annual turnover of: 334.00 vs. QLENX (0.00). QLENX (2500) and SRUAX (2500) have matching initial minimum investment requirements. QLENX annual gain was more profitable for investors over the last year : 24.28 vs. SRUAX (14.57). QLENX return over 5 years is better than : 94.94 vs. SRUAX (31.15).
QLENXSRUAXQLENX / SRUAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years8 years-
Gain YTD20.76216.309127%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.93B220M877%
Annual Yield % from dividends18.521.461,268%
Returns for 1 year24.2814.57167%
Returns for 3 years89.236.391,396%
Returns for 5 years94.9431.15305%
Returns for 10 years121.35N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OM0.650.12
+22.39%
Outset Medical
FA19.660.16
+0.82%
First Advantage Corp
KRT25.94-0.01
-0.04%
Karat Packaging
UNM56.24-0.16
-0.28%
Unum Group
GLMD6.83-8.27
-54.77%
Galmed Pharmaceuticals Ltd